232 related articles for article (PubMed ID: 23361497)
1. Local excision with adjuvant imatinib therapy for anorectal gastrointestinal stromal tumors.
Centonze D; Pulvirenti E; Pulvirenti D'Urso A; Franco S; Cinardi N; Giannone G
Tech Coloproctol; 2013 Oct; 17(5):571-4. PubMed ID: 23361497
[TBL] [Abstract][Full Text] [Related]
2. Anorectal gastrointestinal stromal tumors: a retrospective multicenter analysis of 15 cases emphasizing their high local recurrence rate and the need for standardized therapeutic approach.
Agaimy A; Vassos N; Märkl B; Meidenbauer N; Köhler J; Spatz J; Hohenberger W; Haller F; Croner RS; Schneider-Stock R; Matzel K
Int J Colorectal Dis; 2013 Aug; 28(8):1057-64. PubMed ID: 23404343
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant imatinib in a gastrointestinal stromal tumor of the rectum: report of a case.
Ebihara Y; Okushiba S; Kawarada Y; Kitashiro S; Katoh H; Kondo S
Surg Today; 2008; 38(2):174-7. PubMed ID: 18239881
[TBL] [Abstract][Full Text] [Related]
4. Follow-up strategies for patients with gastrointestinal stromal tumour treated with or without adjuvant imatinib after surgery.
Joensuu H; Martin-Broto J; Nishida T; Reichardt P; Schöffski P; Maki RG
Eur J Cancer; 2015 Aug; 51(12):1611-7. PubMed ID: 26022432
[TBL] [Abstract][Full Text] [Related]
5. Gastrointestinal stromal tumour of the rectum: report of a case and review of literature.
Grassi N; Cipolla C; Torcivia A; Mandala S; Graceffa G; Bottino A; Latteri F
World J Gastroenterol; 2008 Feb; 14(8):1302-4. PubMed ID: 18300363
[TBL] [Abstract][Full Text] [Related]
6. [A case of multiple metastatic giant rectal GIST successfully treated with surgical intervention after administration of imatinib mesylate].
Kitamura D; Ikeda K; Unotoro J; Seki E; Gonda H; Izumi H
Nihon Shokakibyo Gakkai Zasshi; 2013 Jan; 110(1):74-80. PubMed ID: 23303232
[TBL] [Abstract][Full Text] [Related]
7. Which is the best surgical approach for anorectal gastrointestinal stromal tumors in the post-imatinib era?
Pucciarelli S; Maretto I
Tech Coloproctol; 2013 Oct; 17(5):477-8. PubMed ID: 23624793
[No Abstract] [Full Text] [Related]
8. Laparoscopic resection of a gastrointestinal stromal tumor of the rectum after treatment with imatinib mesylate: report of a case.
Nakamura T; Mitomi H; Onozato W; Sato T; Ikeda A; Naito M; Ogura N; Kamata H; Ooki A; Watanabe M
Surg Today; 2012 Nov; 42(11):1096-9. PubMed ID: 22294424
[TBL] [Abstract][Full Text] [Related]
9. [Clinicopathological analysis of 61 patients with rectal gastrointestinal stromal tumors].
Wu X; Jiang W; Zhang R; Ding P; Chen G; Lu Z; Li L; Fang Y; Wang F; Kong L; Lin J; Pan Z; Wan D
Zhonghua Wei Chang Wai Ke Za Zhi; 2014 Apr; 17(4):335-9. PubMed ID: 24760640
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal stromal tumor of the rectum: results of surgical and multimodality therapy in the era of imatinib.
Jakob J; Mussi C; Ronellenfitsch U; Wardelmann E; Negri T; Gronchi A; Hohenberger P
Ann Surg Oncol; 2013 Feb; 20(2):586-92. PubMed ID: 22965573
[TBL] [Abstract][Full Text] [Related]
11. [Curative resection for bulky rectal gastrointestinal stromal tumor after neoadjuvant imatinib mesylate].
Kobayashi H; Uetake H; Higuchi T; Enomoto M; Yasuno M; Iida S; Yoshimura T; Ishikawa T; Ishiguro M; Kato S; Ono H; Kikuchi A; Yamauchi S; Sugihara K
Gan To Kagaku Ryoho; 2010 Nov; 37(12):2620-2. PubMed ID: 21224658
[TBL] [Abstract][Full Text] [Related]
12. Treatment strategy of rectal gastrointestinal stromal tumor (GIST).
Liu H; Yan Z; Liao G; Yin H
J Surg Oncol; 2014 Jun; 109(7):708-13. PubMed ID: 24510506
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for gastrointestinal stromal tumor recurrence in patients treated with adjuvant imatinib.
Joensuu H; Eriksson M; Hall KS; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Ballman KV; Leinonen M; DeMatteo RP; Reichardt P
Cancer; 2014 Aug; 120(15):2325-33. PubMed ID: 24737415
[TBL] [Abstract][Full Text] [Related]
14. One vs three years of adjuvant imatinib for operable gastrointestinal stromal tumor: a randomized trial.
Joensuu H; Eriksson M; Sundby Hall K; Hartmann JT; Pink D; Schütte J; Ramadori G; Hohenberger P; Duyster J; Al-Batran SE; Schlemmer M; Bauer S; Wardelmann E; Sarlomo-Rikala M; Nilsson B; Sihto H; Monge OR; Bono P; Kallio R; Vehtari A; Leinonen M; Alvegård T; Reichardt P
JAMA; 2012 Mar; 307(12):1265-72. PubMed ID: 22453568
[TBL] [Abstract][Full Text] [Related]
15. Laparoscopic sphincter-preserving surgery (intersphincteric resection) after neoadjuvant imatinib treatment for gastrointestinal stromal tumor (GIST) of the rectum.
Fujimoto Y; Akiyoshi T; Konishi T; Nagayama S; Fukunaga Y; Ueno M
Int J Colorectal Dis; 2014 Jan; 29(1):111-6. PubMed ID: 24018650
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy observation on imatinib adjuvant therapy with longer duration in patients with gastrointestinal stromal at intermediate or high risk of recurrence].
Li J; Dang YZ; Gao J; Shen L
Zhonghua Wei Chang Wai Ke Za Zhi; 2013 Mar; 16(3):216-20. PubMed ID: 23536338
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of adjuvant imatinib therapy in improving the prognosis of patients with colorectal gastrointestinal stromal tumours.
Li Y; Meng X
Ann R Coll Surg Engl; 2015 Apr; 97(3):215-20. PubMed ID: 26263807
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and economic value of adjuvant imatinib for gastrointestinal stromal tumors.
Rutkowski P; Gronchi A
Oncologist; 2013 Jun; 18(6):689-96. PubMed ID: 23709752
[TBL] [Abstract][Full Text] [Related]
19. 'Time is a GIFT in GIST'--the medical and paramedical perspective of a case with metastatic gastrointestinal stromal tumor.
Sevinc A; Camci C
Chemotherapy; 2009; 55(1):11-4. PubMed ID: 18974643
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy with imatinib mesylate after resection of primary high-risk gastrointestinal stromal tumors in Japanese patients.
Kanda T; Nishida T; Wada N; Kobayashi O; Yamamoto M; Sawaki A; Boku N; Koseki M; Doi T; Toh Y; Kakeji Y; Sugiyama T; Komatsu Y; Kikuchi S; Ogoshi K; Katai H; Miyachi K; Hirota S; Ohtsu A
Int J Clin Oncol; 2013 Feb; 18(1):38-45. PubMed ID: 22105894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
